valueequityanalysis.com

Independent, business-by-business valuations built from company filings — owner earnings, a ten-year outlook, and a bear / base / bull range. Search a ticker to see our estimate of what the business is worth.

Not investment advice. We are not registered investment advisers, and the people behind this site may hold or trade positions in companies analyzed here. Full disclosures.

Cinemark Holdings, Inc. (CNK) stock intrinsic value fair value estimate & owner earnings analysis

Margin of safety$14.00 ComplexityAverage Updated
$10.36 $33.90
bear $10.36 base $23.00 bull $33.90 margin of safety $14.00 market price* $38.48
Cinemark is the third-largest US movie-theater chain. It runs nearly 500 theaters and more than 5,500 screens in 42 US states and 13 other countries, mostly in Latin America. Revenue comes from ticket sales, concessions and screen advertising. It is a film-supply business. Studios decide what gets released and how long a film stays exclusive to theaters, and audiences decide whether to show up. What the business earns. We measure earnings as cash from operations, less swings in working capital, less stock compensation, less the part of capital spending needed to keep the theaters running. On that basis Cinemark earned per share about $1.35 in 2016, $1.14 in 2017, $2.01 in 2018 and $1.75 in 2019. The pandemic years were a loss of $3.46 in 2020 and $0.16 in 2021, then $0.97 in 2022 as theaters reopened. It then earned $1.89 in 2023, $1.43 in 2024 and $1.17 in 2025. We ignore 2020 to 2022, because closures and the reopening distort them. The business as it exists today is best described by 2023 to 2025, when owner earnings were roughly $288 million, $222 million and $156 million. The per-share figures for 2023 and 2024 are lowered by 152 to 155 million diluted shares, which count the shares that convertible notes could become. Those notes matured in August 2025, and buybacks and conversions have since brought the count down to about 115 million. Owner earnings fell about 30% in 2025. The main reason is capital spending. It rose from $151 million in 2024 to $219 million in 2025, and the most recent twelve months are running higher still. Depreciation of about $200 million a year suggests that this higher level is roughly what it costs to keep theaters and premium screens current. So we do not treat 2024's low spending as the normal level. We start from about $190 million a year of owner earnings, between the 2025 figure and the three-year median of $222 million. Cash from operations was $444 million in 2023, $466 million in 2024 and $396 million in 2025. An accounting point: 2024 net income of about $310 million is far above cash earnings. Most of the gap is a $137 million release of a tax valuation allowance, a non-cash benefit. Our measure starts from cash, so it is unaffected. We take no credit for a rebound in the first half of 2026. First-quarter revenue rose about 19%, and the second quarter was the first above $1 billion, with record ticket and concession sales. That is encouraging. But it rests on a strong film slate, and we cannot name a contract or structural feature behind it. The strong quarters are enough to support the starting level, not to lift it. Base case, $23.00 a share. Owner earnings start at $190 million and drift down about 1% a year. Attendance was flat to slightly down before the pandemic, and the streaming competition and shortened release windows already in evidence have not gone away. Nothing we can name and evidence justifies assuming growth. What persists is a base of well-located theaters, a Movie Club with 1.5 million members that accounts for about 30% of domestic box office, and premium formats such as XD, ScreenX and D-BOX. Bull case, $33.90 a share. Owner earnings stabilize at about $240 million, roughly the 2018 to 2023 range, and then hold without decline. This needs capital spending to ease toward $150 to $200 million as current theater and premium-screen investments finish. Cinemark earned $233 million in 2018 and $288 million in 2023, both normal years. Bear case, $10.36 a share. Owner earnings sit near $110 million and shrink about 3% a year. Capital spending stays near the recent $220 million to $270 million range. Studios keep shortening theatrical windows or cutting wide releases, and attendance erodes. Cash flow is already after interest on about $1.9 billion of debt, made up of $765 million of 5.25% notes due 2028, $500 million of 7.00% notes due 2032 and a $632 million term loan due 2030. That leverage sharpens the downside. Cinemark showed how exposed it is to film supply in 2020, when owner earnings were deeply negative. The margin-of-safety price is about $14.00, well below the base value. The margin is wide because earnings depend on studio release schedules and consumer habits, the company carries meaningful debt, and 2025 owner earnings fell rather than rose. Trailing owner-earnings growth in 2025 was about minus 30%, and our base case begins at minus 1% from an anchor already above 2025's level, because first-half 2026 revenue is well above the prior year. What could prove this wrong: owner earnings could rise well above $190 million if the 2026 box-office strength is a lasting change in how often people go to the movies. They could fall further if studios shift toward streaming or capital spending keeps climbing.
Fiscal yearOwner's earningsMethodology
2025 $1.17 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$396.1M (company earnings release); WC cash effect=$(10.2)M (approx; removed); SBC=$36.5M; capex=$218.9M, growth capex=$5.5M (8.4% x revenue change $65.5M), maintenance capex=$213.4M; OE=$156.4M; diluted shares=134.3M; OE/sh=$1.165. Source: FY2025 10-K accession 0001193125-26-056015.
2024 $1.43 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$466.0M (company earnings release); WC cash effect=+$59.9M (approx; removed); SBC=$33.5M; capex=$150.8M, revenue declined so growth capex=0, maintenance capex=$150.8M; OE=$221.8M; diluted shares=154.9M; OE/sh=$1.432. Source: FY2024 10-K accession 0000950170-25-022756.
2023 $1.89 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$444.3M (company earnings release); WC cash effect=+$33.3M (approx, aggregator lines; removed); SBC=$25.0M; capex=$149.5M, growth capex=$51.4M (revenue change $612.0M), maintenance capex=$98.1M; OE=$287.9M; diluted shares=152.0M (includes convertible note dilution); OE/sh=$1.894. Source: FY2023 10-K accession 0000950170-24-016143.
2022 $0.97 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$136.0M (company FY2023 earnings release; not in stored XBRL); WC cash effect=$(31.9)M (AR, inventory, AP, other net; data-aggregator figures, approximate); SBC=$21.5M; capex=$110.7M, growth capex=$79.3M (revenue change $944.2M), maintenance capex=$31.4M; OE=$115.0M; diluted shares=118.2M; OE/sh=$0.973. Recovery year, excluded from anchor. Source: FY2022 10-K accession 0000950170-23-004235 (values via XBRL for SBC/revenue).
2021 -$0.16 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$166.2M; WC cash effect=+$129.1M (removed); SBC=$29.3M; capex=$95.5M, growth capex=$69.2M (8.4% x revenue change $824.2M), maintenance capex=$26.3M; OE=$(18.5)M; diluted shares=117.3M; OE/sh=$(0.158). COVID-distorted, excluded from anchor. Source: FY2021 10-K accession 0000950170-22-002035.
2020 -$3.46 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$(330.1)M; WC cash effect=$(29.7)M (removed); SBC=$19.4M; capex=$83.9M, revenue declined so growth capex=0, maintenance capex=$83.9M; OE=$(403.7)M; shares=116.667M; OE/sh=$(3.460). COVID closure year, excluded from anchor. Source: FY2020 10-K accession 0001564590-21-009190.
2019 $1.75 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$562.0M; WC cash effect=+$45.1M (removed); SBC=$14.6M; capex=$303.6M, growth capex=$5.1M (revenue change $61.4M), maintenance capex=$298.5M; OE=$203.8M; diluted shares=116.606M; OE/sh=$1.748. Source: FY2019 10-K accession 0001564590-20-005646.
2018 $2.01 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$556.9M; WC cash effect=$(17.8)M (removed); SBC=$14.3M; capex=$346.1M, growth capex=$19.3M (8.4% x revenue change $230.2M), maintenance capex=$326.8M; OE=$233.6M; diluted shares=116.342M; OE/sh=$2.008. Source: FY2018 10-K accession 0001564590-19-005358.
2017 $1.14 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$529.0M; WC cash effect=+$9.7M (removed); SBC=$12.7M; capex=$380.9M, capex_ratio 8.4% x revenue change $72.8M = growth capex $6.1M, maintenance capex=$374.8M; OE=$131.8M; diluted shares=116.059M; OE/sh=$1.136. Source: FY2017 10-K accession 0001564590-18-002969.
2016 $1.35 ▼
OE = CFO - WC movement - SBC - maintenance capex. CFO=$462.9M; WC cash effect=$(32.2)M (AR, inventory, AP/accrued; removed); SBC=$13.4M; capex=$326.9M, growth capex ~$1M (revenue ~flat vs 2015) so maintenance capex ~$325.9M; OE=$155.8M; diluted shares=115.783M; OE/sh=$1.346. Source: FY2016 10-K accession 0001193125-17-052899 and FY2018 10-K 0001564590-19-005358.

Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.

Sales geography
United States (theaters in 42 states) and 13 other countries, primarily Latin America (Brazil, Argentina, Chile, Colombia, Peru, Ecuador and others)
Historical growth strategy

We don't have historical growth strategy information for this company yet.

Chart analysis

We don't have chart analysis for this company yet.

Competitors

We don't have competitor information for this company yet.

Circle of competence

We don't have circle of competence information for this company yet.